文献速递创伤与烧伤复苏、休克与脓毒症重症综合管理与镇静镇痛

联合创伤性脑损伤与失血性休克的多模式治疗方法改变伤后炎症反应

MULTIMODAL TREATMENT APPROACHES TO COMBINED TRAUMATIC BRAIN INJURY AND HEMORRHAGIC SHOCK ALTER POSTINJURY INFLAMMATORY RESPONSE.
PubMed 文献 · Shock · 2022-11-04
一句话结论小鼠实验显示,全血复苏较羟乙基淀粉可减轻联合创伤性脑损伤与失血性休克后的急性神经炎症反应,加用普萘洛尔或氨甲环酸可能调节炎症反应。

本研究在小鼠创伤性脑损伤后失血性休克模型中,比较羟乙基淀粉(HTS)与失血全血(WB)复苏,并评估普萘洛尔(4 mg/kg 腹腔注射)、氨甲环酸(TXA,100 mg/kg 腹腔注射)或生理盐水对照的炎症效应。HTS复苏组在伤后6和24小时血清促炎细胞因子高于WB组,脑细胞因子无显著差异。WB复苏加用普萘洛尔和TXA后血清促炎细胞因子升高,但普萘洛尔组脑IL-2、IL-12、MIP-1α降低;HTS加TXA组血清神经元特异性烯醇化酶在伤后1和24小时显著升高,WB加普萘洛尔组在24小时显著降低。作者认为全血复苏可减轻急性神经炎症反应,多模式治疗可能改善恢复。

要点

  • 小鼠联合创伤性脑损伤与失血性休克模型中,HTS复苏组伤后6和24小时血清促炎细胞因子高于WB复苏组,脑细胞因子无显著差异。
  • WB复苏加用普萘洛尔或TXA后,伤后6和24小时血清IL-2、IL-12、MIP-1α、IL-1β较生理盐水对照升高。
  • WB复苏加用普萘洛尔组伤后6小时脑IL-2、IL-12、MIP-1α较生理盐水组显著降低,伤后24小时血清神经元特异性烯醇化酶也显著降低。
  • HTS复苏加用TXA组伤后1和24小时血清神经元特异性烯醇化酶较生理盐水对照显著升高。
  • 作者认为全血复苏可减轻急性神经炎症反应,加用普萘洛尔或TXA可能调节全身和脑炎症反应,普萘洛尔改善更明显。

适用人群与场景

  • 小鼠,体重跌落致创伤性脑损伤后,接受控制性失血性休克1小时至目标平均动脉压25 mmHg。

诊断标准与关键阈值

  • 创伤性脑损伤通过体重跌落法诱导;失血性休克目标平均动脉压为25 mmHg,持续1小时。

处置流程与药物剂量

  • 小鼠随机分为HTS复苏组和WB复苏组,每组再分别接受普萘洛尔4 mg/kg腹腔注射、TXA 100 mg/kg腹腔注射或生理盐水对照。
  • 伤后1、6或24小时处死小鼠,用多重ELISA检测血清和脑生物标志物,并检测血清神经元特异性烯醇化酶。

研究设计与关键结果

  • 研究类型为小鼠实验;样本量原文未报告;HTS复苏组伤后6和24小时血清促炎细胞因子高于WB复苏组,脑细胞因子水平无显著差异。
  • 在TBI/休克+HTS组中,加用普萘洛尔或TXA未显著改变血清细胞因子浓度,但普萘洛尔给药后脑IL-2、IL-12和巨噬细胞炎症蛋白-1α(MIP-1α)降低。
  • 在TBI/休克+WB组中,加用普萘洛尔和TXA后伤后6和24小时血清IL-2、IL-12、MIP-1α和IL-1β较生理盐水对照升高。
  • TBI/休克+WB小鼠中,普萘洛尔治疗组伤后6小时脑IL-2、IL-12和MIP-1α较生理盐水组显著降低。
  • TBI/休克+HTS+TXA组伤后1和24小时血清神经元特异性烯醇化酶较生理盐水对照显著升高;TBI/休克+WB+普萘洛尔组伤后24小时血清神经元特异性烯醇化酶较生理盐水对照显著降低。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,联合创伤性脑损伤与失血性休克后,全血复苏相比HTS可减轻急性伤后神经炎症反应。
  • 作者认为,加用普萘洛尔或TXA可能调节伤后全身和脑炎症反应,普萘洛尔给药后改善更明显。
  • 作者认为,复苏联合药物治疗的多模式治疗可能减轻损伤炎症反应以改善恢复。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Introduction: The optimal management strategies for patients with polytraumatic injuries that include traumatic brain injury (TBI) are not well defined. Specific interventions including tranexamic acid (TXA), propranolol, and hypertonic saline (HTS) have each demonstrated benefits in patient mortality after TBI, but have not been applied to TBI patients with concomitant hemorrhage. The goals of our study were to determine the inflammatory effects of resuscitation strategy using HTS or shed whole blood (WB) and evaluate the cerebral and systemic inflammatory effects of adjunct treatment with TXA and propranolol after combined TBI + hemorrhagic shock. Methods: Mice underwent TBI via weight drop and were subsequently randomized into six experimental groups: three with HTS resuscitation and three with WB resuscitation. Mice were then subjected to controlled hemorrhagic shock for 1 h to a goal MAP of 25 mmHg. Mice were then treated with an i.p. dose of 4 mg/kg propranolol, 100 mg/kg TXA, or normal saline (NS) as a control. Mice were killed at 1, 6, or 24 h for serum and cerebral biomarker evaluation by multiplex ELISA and serum neuron-specific enolase, a biomarker of cerebral cellular injury. Results: Mice resuscitated with HTS had elevated serum proinflammatory cytokines compared with WB resuscitated groups at 6 and 24 h after injury, with no significant difference in cerebral cytokine levels. Within the TBI/shock + HTS groups, the addition of propranolol or TXA did not significantly alter serum cytokine concentration, but cerebral IL-2, IL-12, and macrophage inflammatory protein-1α (MIP-1α) decreased after propranolol administration. In the TBI/shock + WB cohorts, the addition of both propranolol and TXA increased systemic proinflammatory cytokine levels at 6 and 24 h after injury as demonstrated by serum IL-2, IL-12, MIP-1α, and IL-1β compared with NS control. By contrast, TBI/shock + WB mice demonstrated a significant reduction in cerebral IL-2, IL-12, and MIP-1α in propranolol treated mice 6 h after injury compared with NS group. While serum neuron-specific enolase was significantly increased 1 and 24 h after injury in TBI/shock + HTS + TXA cohorts compared with NS control, it was significantly reduced in the TBI/shock + WB + propranolol mice compared with NS control 24 h after injury. Conclusions: Whole blood resuscitation can reduce the acute postinjury neuroinflammatory response after combined TBI/shock compared with HTS. The addition of either propranolol or TXA may modulate the postinjury systemic and cerebral inflammatory response with more improvements noted after propranolol administration. Multimodal treatment with resuscitation and pharmacologic therapy after TBI and hemorrhagic shock may mitigate the inflammatory response to these injuries to improve recovery.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Wallen TE, Baucom MR, England LG, et al. MULTIMODAL TREATMENT APPROACHES TO COMBINED TRAUMATIC BRAIN INJURY AND HEMORRHAGIC SHOCK ALTER POSTINJURY INFLAMMATORY RESPONSE. Shock. 2022. PMID: 36548646. doi:10.1097/SHK.0000000000002014

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。